CT26-hTROP2

Export PDF

Strain Information

Cell Line

CT26-hTROP2

Cat. NO.

NM-S24A-TM38

Model Description

TROP2 gene humanized CT26 cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig.1 hTROP2 expression on in vitro cultured cells of CT26-hTROP2.

image.png

Fig.2 In vivo validation of CT26-hTROP2 in BALB/c mice.BALB/c mice were inoculated with CT26-hTROP2 subcutaneously at 3×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 7th day after vaccination, twice a week.

image.png

Fig.3 hTROP2 expression in tumors after in vivo growth of CT26-hTROP2 in wild type BALB/c mice.When the MTV reaches 500-800 mm3, take one tube from each group and send it to FACS for testing (Markers: L/D, mCD45, hTROP2). A，the MTV reaches 800 mm3. B，the MTV reaches 1500 mm3.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more